| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 305EB53128 |
| InChI Key | VOFLAIHEELWYGO-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H9Cl2NO4S |
| Molecular Weight | 358.2 |
| AlogP | 3.09 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 74.68 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 22.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Solute carrier family 22 member 12 inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 5700 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 37-6800 | - | - | 78-81 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hyperuricemia | 2 | D033461 | ClinicalTrials |
| Renal Insufficiency | 1 | D051437 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594446 |
| FDA SRS | 305EB53128 |
| PubChem | 51349053 |
| SureChEMBL | SCHEMBL10322525 |